Subclinical Hyperthyroidism To Treat or Not to Treat? A Dutch Multicenter Trial.
Recruiting
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 192
Inclusion Criteria
1. Subclinical hyperthyroidism [TSH <= 0.1 mU/L, fT4 and T3 within the normal range
of the own laboratory (determined 2 times in own laboratory with an interval of at
least 2 months];
Exclusion Criteria
1. Medication with anti-thyroid drugs in the last 3 months (also not allowed during
follow-up), thyroid hormone in the last 3 months (allowed during follow-up, but TSH levels should be kept between 0.1 mU/L and the upper limit of normal in the
own laboratory) and oral glucocorticoids in the last 3 months (allowed during
follow-up when absolutely necessary, but patients in whom glucocorticoids are
started cannot be evaluated with respect to changes in BMD);
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method